港股公告掘金 | 东方证券拟通过发行A股股份及支付现金方式购买上海证券100%股权_老虎社区_美港股上老虎

港股公告掘金 | 东方证券拟通过发行A股股份及支付现金方式购买上海证券100%股权

智通财经05-07

重大事项：石四药集团(02005)取得甲磺酸多沙唑嗪缓释片(4mg)等药品的生产注册批件中国生物制药(01177)：库莫西利胶囊“CDK2/4/6抑制剂”一线治疗乳腺癌新适应症获批上市佰金生命科学(01466)附属与扶摇元气订立策略合作框架协议开展临床细胞治疗领域的策略合作石四药集团(02005)：全量程C反应蛋白(hsCRP+常规CRP)检测试剂盒及血清淀粉样蛋白A/C反应蛋白(SAA/CRP...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

暂无评论

热议股票

7x24

全部

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2633164997?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-05-07 09:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2633164997","market":"sh","top_or_hot":-1,"title":"港股公告掘金 | 东方证券拟通过发行A股股份及支付现金方式购买上海证券100%股权","media":"智通财经","content":"<div>\n<p>重大事项：石四药集团(02005)取得甲磺酸多沙唑嗪缓释片(4mg)等药品的生产注册批件中国生物制药(01177)：库莫西利胶囊“CDK2/4/6抑制剂”一线治疗乳腺癌新适应症获批上市佰金生命科学(01466)附属与扶摇元气订立策略合作框架协议 开展临床细胞治疗领域的策略合作石四药集团(02005)：全量程C反应蛋白(hsCRP+常规CRP)检测试剂盒及血清淀粉样蛋白A/C反应蛋白(SAA/CRP...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1438848.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股公告掘金 | 东方证券拟通过发行A股股份及支付现金方式购买上海证券100%股权</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股公告掘金 | 东方证券拟通过发行A股股份及支付现金方式购买上海证券100%股权\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-05-07 09:00 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1438848.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>重大事项：石四药集团(02005)取得甲磺酸多沙唑嗪缓释片(4mg)等药品的生产注册批件中国生物制药(01177)：库莫西利胶囊“CDK2/4/6抑制剂”一线治疗乳腺癌新适应症获批上市佰金生命科学(01466)附属与扶摇元气订立策略合作框架协议 开展临床细胞治疗领域的策略合作石四药集团(02005)：全量程C反应蛋白(hsCRP+常规CRP)检测试剂盒及血清淀粉样蛋白A/C反应蛋白(SAA/CRP...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1438848.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"600958","symbol_name":"东方证券","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1438848.html","article_id":"2633164997","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2633164997","pubTimestamp":1778115646,"columns":[{"name":"A股","id":33,"label_key":"policyRegulatory"}],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"重大事项：石四药集团(02005)取得甲磺酸多沙唑嗪缓释片(4mg)等药品的生产注册批件中国生物制药(01177)：库莫西利胶囊“CDK2/4/6抑制剂”一线治疗乳腺癌新适应症获批上市佰金生命科学(01466)附属与扶摇元气订立策略合作框架协议 开展临床细胞治疗领域的策略合作石四药集团(02005)：全量程C反应蛋白(hsCRP+常规CRP)检测试剂盒及血清淀粉样蛋白A/C反应蛋白(SAA/CRP","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159982":"中证500","161027":"证券","399300":"沪深300","600958":"东方证券","VXUS":"国际股票ETF-Vanguard","03958":"东方证券","BK1515":"抗疫概念","IE00BZ08YT58.USD":"GUINNESS BEST OF CHINA \"C\" (USD) ACC","BK4585":"ETF&股票定投概念","BK1147":"投资银行业与经纪业","BK0012":"证金概念","02005":"石四药集团","01466":"佰金生命科学","BK1521":"挪威政府全球养老基金持仓","HK0000165453.HKD":"华夏精选大中华科技基金 A类港币","BK1227":"服装、服饰与奢侈品","BK0183":"MSCI概念","BK1589":"北水核心资产","BK0188":"融资融券","BK4588":"碎股","01177":"中国生物制药","LU2460026573.USD":"abrdn SICAV I -  CHINA NEXT GENERATION \"A\" (USD) ACC","IE00BZ08YR35.GBP":"GUINNESS BEST OF CHINA \"C\" (GBP) ACC","BK1564":"中资券商股","IE00BZ08YS42.EUR":"GUINNESS BEST OF CHINA \"C\" (EUR) ACC","BK0028":"国家队","BK0276":"资本市场","BK1191":"制药"},"translate_title":"Hong Kong Stock Announcement Nuggets | Orient Securities intends to purchase 100% equity of Shanghai Securities by issuing A shares and paying cash","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159982":1.5,"161027":1.5,"399300":1.5,"600958":1.5,"VXUS":1.5,"01466":0.9,"02005":0.9,"01177":0.9,"03958":1.5},"content_text":"重大事项：石四药集团(02005)取得甲磺酸多沙唑嗪缓释片(4mg)等药品的生产注册批件中国生物制药(01177)：库莫西利胶囊“CDK2/4/6抑制剂”一线治疗乳腺癌新适应症获批上市佰金生命科学(01466)附属与扶摇元气订立策略合作框架协议 开展临床细胞治疗领域的策略合作石四药集团(02005)：全量程C反应蛋白(hsCRP+常规CRP)检测试剂盒及血清淀粉样蛋白A/C反应蛋白(SAA/CRP)检测试剂盒获中国河北药监局颁发医疗器械注册证东方证券(03958)拟通过发行A股股份及支付现金方式购买上海证券100%股权中国生物制药(01177)：克非奇拜单抗“CCR8单抗”二线治疗胃癌Ⅲ期注册临床试验完成首例患者入组科笛-B(02487)：CU-30101(局部外用利多卡因丁卡因乳膏剂)获国家药监局药品上市许可经营业绩：锦欣生殖(01951)前4个月不孕初诊数同比增长7.5% 取卵周期数同比增长5.2%牧原股份(02714)4月商品猪销售收入约85.03亿元，同比下降32.49%广汽集团(02238)4月汽车销量12.096万辆 同比增长3.88%第一太平(00142)：MPIC第一季度取得综合核心溢利净额69亿比索 同比增加5%","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}